Cancer cachexia and fatigue.
نویسندگان
چکیده
Cachexia is a disease process that develops in numerous chronic, end-stage disease processes (eg cancer, heart failure, AIDS, renal failure). It has no agreed definition but represents the complex metabolic process that occurs in patients with these conditions.1 Cachectic patients lose lean muscle mass as well as fat, unlike starvation where only fat stores are initially depleted. In addition, the muscle wasting of cachexia cannot be reversed by increased food intake alone.2,3 Weight loss is the symptom most commonly associated with cachexia but there are numerous other features (Table 1),1 of which fatigue is an important one (70–100% of cancer patients).4 Cancer cachexia is common. Half of all patients with cancer lose some body weight; one-third lose more than 5% of their original body weight and up to 20% of all cancer deaths are caused directly by cachexia (through immobility, cardiac/ respiratory failure).5 Cachexia is particularly prominent in solid tumours of the upper gastrointestinal (GI) tract and lung (Table 2). Weight loss is a prognostic factor in the survival of cancer patients and is associated with a reduced response to chemoradiotherapy.2
منابع مشابه
The Role of microRNA in Cancer Cachexia and Muscle Wasting: A Review Article
Almost half of cancer patients experience cachexia syndrome. Cachexic patients are at risk of increased side effects of chemotherapy, reduced tolerance to chemotherapy drugs, longer duration of treatment period, and decreased quality of life. Cancer cachexia is a multifactorial syndrome. Micro ribonucleic acid (miRNA), a “non-coding RNA”, is considered to be a risk factor of cachexia and muscle...
متن کاملl-carnitine and cancer cachexia: Clinical and experimental aspects
Cancer cachexia is a multifaceted syndrome characterized, among many symptoms, by extensive muscle wasting. Chronic systemic inflammation, partly triggered and sustained by cytokines, as well as increased oxidative stress contributes to the pathogenesis of this complex metabolic disorder. l-carnitine plays a central role in the metabolism of fatty acids and shows important antioxidant and anti-...
متن کاملCachexia as a major underestimated and unmet medical need: facts and numbers
Cachexia is a serious, however underestimated and underrecognised medical consequence of malignant cancer, chronic heart failure (CHF), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), cystic fibrosis, rheumatoid arthritis, Alzheimer's disease, infectious diseases, and many other chronic illnesses. The prevalence of cachexia is high, ranging from 5% to 15% in CHF or C...
متن کاملManagement of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomiting.
Physical symptoms other than pain often contribute to suffering near the end of life. In addition to pain, the most common symptoms in the terminal stages of an illness such as cancer or acquired immunodeficiency syndrome are fatigue, anorexia, cachexia, nausea, vomiting, constipation, delirium and dyspnea. Management involves a diagnostic evaluation for the cause of each symptom when possible,...
متن کاملAn invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada
The National Cancer Institute in the USA has recently placed greater emphasis on cancer cachexia research by identifying this syndrome as a provocative question needing to be addressed in order to drive progress against cancer. Such funding mechanisms are expected to stimulate cutting edge approaches at both the basic and clinical science levels to advance our understanding of the underlying ca...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical medicine
دوره 6 2 شماره
صفحات -
تاریخ انتشار 2006